156 related articles for article (PubMed ID: 30638877)
1. Synthesis and evaluation of novel substituted 1,2,3-triazolyldihydroquinolines as promising antitubercular agents.
Marvadi SK; Krishna VS; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2019 Feb; 29(4):529-533. PubMed ID: 30638877
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel morpholine, thiomorpholine and N-substituted piperazine coupled 2-(thiophen-2-yl)dihydroquinolines as potent inhibitors of Mycobacterium tuberculosis.
Marvadi SK; Krishna VS; Sriram D; Kantevari S
Eur J Med Chem; 2019 Feb; 164():171-178. PubMed ID: 30594675
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and in vitro anti-tuberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,2,3-triazole derivatives.
Sajja Y; Vanguru S; Vulupala HR; Bantu R; Yogeswari P; Sriram D; Nagarapu L
Bioorg Med Chem Lett; 2017 Dec; 27(23):5119-5121. PubMed ID: 29113761
[TBL] [Abstract][Full Text] [Related]
4. 5-Chloro-2-thiophenyl-1,2,3-triazolylmethyldihydroquinolines as dual inhibitors of Mycobacterium tuberculosis and influenza virus: Synthesis and evaluation.
Marvadi SK; Krishna VS; Sinegubova EO; Volobueva AS; Esaulkova YL; Muryleva AA; Tentler DG; Sriram D; Zarubaev VV; Kantevari S
Bioorg Med Chem Lett; 2019 Sep; 29(18):2664-2669. PubMed ID: 31375291
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of dihydroquinoline carboxamide derivatives as anti-tubercular agents.
Kumar G; Sathe A; Krishna VS; Sriram D; Jachak SM
Eur J Med Chem; 2018 Sep; 157():1-13. PubMed ID: 30064024
[TBL] [Abstract][Full Text] [Related]
6. Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis.
Yempala T; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S
Eur J Med Chem; 2014 Jan; 71():160-7. PubMed ID: 24292337
[TBL] [Abstract][Full Text] [Related]
7. A convenient synthesis and screening of benzosuberone bearing 1,2,3-triazoles against Mycobacterium tuberculosis.
Sajja Y; Vanguru S; Jilla L; Vulupala HR; Bantu R; Yogeswari P; Sriram D; Nagarapu L
Bioorg Med Chem Lett; 2016 Sep; 26(17):4292-5. PubMed ID: 27476139
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 1H-pyrrolo[2,3-d]pyrimidine-1,2,3-triazole derivatives as novel anti-tubercular agents.
Shiva Raju K; AnkiReddy S; Sabitha G; Siva Krishna V; Sriram D; Bharathi Reddy K; Rao Sagurthi S
Bioorg Med Chem Lett; 2019 Jan; 29(2):284-290. PubMed ID: 30497913
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and in vitro antitubercular activity of 1,2,3-triazolyl-dihydroquinoline derivatives.
Banu S; Bollu R; Nagarapu L; Nanubolu JB; Yogeswari P; Sriram D; Gunda SK; Vardhan D
Chem Biol Drug Des; 2018 Jul; 92(1):1315-1323. PubMed ID: 29624868
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of quinoline coupled [1,2,3]-triazoles as a promising class of anti-tuberculosis agents.
Karthik Kumar K; Prabu Seenivasan S; Kumar V; Mohan Das T
Carbohydr Res; 2011 Oct; 346(14):2084-90. PubMed ID: 21767828
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and evaluation of 1,2,3-triazole-adamantylacetamide hybrids as potent inhibitors of Mycobacterium tuberculosis.
Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2014 Apr; 24(8):1974-9. PubMed ID: 24679703
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and in vitro anti-mycobacterial evaluation of gatifloxacin-1H-1,2,3-triazole-isatin hybrids.
Xu Z; Zhang S; Song X; Qiang M; Lv Z
Bioorg Med Chem Lett; 2017 Aug; 27(16):3643-3646. PubMed ID: 28720502
[TBL] [Abstract][Full Text] [Related]
13. Preparation and reactions of sugar azides with alkynes: synthesis of sugar triazoles as antitubercular agents.
Singh BK; Yadav AK; Kumar B; Gaikwad A; Sinha SK; Chaturvedi V; Tripathi RP
Carbohydr Res; 2008 May; 343(7):1153-62. PubMed ID: 18346719
[TBL] [Abstract][Full Text] [Related]
14. Substituted 4-methylquinolines as a new class of anti-tuberculosis agents.
Jain R; Vaitilingam B; Nayyar A; Palde PB
Bioorg Med Chem Lett; 2003 Mar; 13(6):1051-4. PubMed ID: 12643909
[TBL] [Abstract][Full Text] [Related]
15. Click-based synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene-1,2,3-triazoles with piperidine, piperazine, morpholine and thiomorpholine appendages.
Pulipati L; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2016 Jun; 26(11):2649-54. PubMed ID: 27101894
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antituberculosis studies and biological evaluation of new quinoline derivatives carrying 1,2,4-oxadiazole moiety.
Shruthi TG; Eswaran S; Shivarudraiah P; Narayanan S; Subramanian S
Bioorg Med Chem Lett; 2019 Jan; 29(1):97-102. PubMed ID: 30448235
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 3-heteroarylthioquinoline derivatives and their in vitro antituberculosis and cytotoxicity studies.
Chitra S; Paul N; Muthusubramanian S; Manisankar P; Yogeeswari P; Sriram D
Eur J Med Chem; 2011 Oct; 46(10):4897-903. PubMed ID: 21855182
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel triazole, urea and thiourea derivatives of quinoline against Mycobacterium tuberculosis.
Upadhayaya RS; Kulkarni GM; Vasireddy NR; Vandavasi JK; Dixit SS; Sharma V; Chattopadhyaya J
Bioorg Med Chem; 2009 Jul; 17(13):4681-92. PubMed ID: 19457676
[TBL] [Abstract][Full Text] [Related]
20. Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads.
Tanwar B; Kumar A; Yogeeswari P; Sriram D; Chakraborti AK
Bioorg Med Chem Lett; 2016 Dec; 26(24):5960-5966. PubMed ID: 27839684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
